3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
3
Sarcoma
1
Plasma cell
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
pembrolizumab
7
Cyclophosphamide
7
Surveys and Questionnaires
4
Filgrastim
4
aldesleukin
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
Methods
3
Flow Cytometry
3
Early Intervention, Educational
3
valspodar
2
sargramostim
2
fludarabine
2
atezolizumab
2
Therapeutics
2
Stem Cell Factor
2
Sirolimus
2
Methylprednisolone
2
Melphalan
2
Ipilimumab
2
Interleukin-2
2
Immunologic Techniques
2
Exercise
2
Etoposide
2
Epoetin Alfa
2
Educational Status
2
Drug Therapy
2
Data Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Interferons
×
Breast
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled